9ESR image
Deposition Date 2024-03-26
Release Date 2025-09-03
Last Version Date 2025-09-03
Entry Detail
PDB ID:
9ESR
Keywords:
Title:
CDK2-cyclin A in complex with FragLite 23
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Bos taurus (Taxon ID: 9913)
Method Details:
Experimental Method:
Resolution:
2.39 Å
R-Value Free:
0.22
R-Value Work:
0.22
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Cyclin-dependent kinase 2
Gene (Uniprot):CDK2
Chain IDs:A, C
Chain Length:302
Number of Molecules:2
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Cyclin-A2
Gene (Uniprot):CCNA2
Chain IDs:B, D
Chain Length:268
Number of Molecules:2
Biological Source:Bos taurus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
TPO A THR modified residue
Ligand Molecules
Primary Citation
Crystallographic fragment screening of CDK2-cyclin A: FragLites map sites of protein-protein interaction.
Structure ? ? ? (2025)
PMID: 40816275 DOI: 10.1016/j.str.2025.07.016

Abstact

Sites of protein-protein interaction (PPI) are potentially more selective binding sites for therapeutics than protein substrate-binding sites. PPIs include distinct regions frequently called "hotspots," sites of key amino acid interactions. Prospective identification of these hotspots through X-ray crystallographic screening could assist in the identification of separation of function mutants for experimental validation, enhance confidence in AI-generated multiprotein complex predictions, and accelerate development of selective chemical probes. To explore these applications, we utilize the FragLite library to examine the binding surfaces of CDK2-cyclin A. The many protein- and peptide-CDK2-cyclin A complexes that have been structurally characterized make this complex an appropriate test case. We show that FragLites comprehensively map both known sites of protein-protein interaction on CDK2-cyclin A and identify a possible uncharacterized site, providing a structural method toward directing mechanistic studies and starting points for chemical probe design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures